Seeking Alpha

BMRN
  BioMarin Pharmaceutical Inc. - NASDAQ

10/2/2014, 1:18 PM ET
  • freefdawatchlist | Send Message 5 Nov 2012

    http://bit.ly/SNycwr Premarket Gainer and Loser for Nov 5th: $BMRN, $NTP, $EQU, $SF, $MAPP, $MEI, $MEG, $RDN
    Reply
      BMRN vs. ETF Alternatives
      Company Description
      Biomarin Pharmaceutical Inc develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its product portfolio is comprised of five product candidates Naglazyme, Kuvan, Aldurazyme, VIMIZIM and Firdapse.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States